Iglehart and Thompson: Does the AMA Need “A Different Model of Advocacy”?

Jeff Thompson MD The AMA’s vigorous opposition this week to the FDA’s consideration of mandating training for opioid prescribers to curb the current opioid epidemic (which the AMA’s liberal policies toward specialty designation and pharmaceutical underwriting helped create), called to mind the words in 2009 of Gunderson-Lutheran neonatologist and CEO, Jeff Thompson in an interview […]

The post Iglehart and Thompson: Does the AMA Need “A Different Model of Advocacy”? appeared first on HealthCommentary.